about
The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and DiseasesWillingness to pay for a new drug delivery in Parkinson patientsRole for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian miceRole for the nicotinic cholinergic system in movement disorders; therapeutic implications.The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeysA Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal functionα4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseTreatment of Parkinson's disease: what's in the non-dopaminergic pipeline?ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.Effect of nicotine on L-dopa-induced dyskinesia in animal models of Parkinson's disease: a systematic review and meta-analysis.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.The nicotine-mediated decline in l-dopa-induced dyskinesias is associated with a decrease in striatal dopamine release.Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways.
P2860
Q28067014-CF819997-09E9-40F0-BFC9-95CF57CA23EDQ30428083-79F9E7B4-EA1D-471F-9F13-6D2640514EE3Q30450052-8758D361-4DAC-4F56-A9F8-5C479B178F53Q34112026-7B0E01FA-3D3A-4146-97DC-E45648355F6CQ34186299-7DF70768-07FA-4E95-BF08-2BE531384B80Q35324207-3FB61906-9AEF-48FB-8409-EA8CC7E13B39Q36469995-2F99C9F6-A52E-4776-8F19-BC45B47BA239Q36704078-F44D734B-0834-4A3E-976D-6936BD0DFE9BQ36936920-80D6040A-817A-497B-9833-2F968C933A3CQ36936930-2E4CE6F8-4A95-4B9C-88D5-8D23E07F115CQ37193201-EAE33C6C-3B46-44FD-82C1-785E36228910Q37209730-AF50BFC5-C7CE-4151-9FA2-4ABCD51C5669Q37506507-DDF127D8-0FA4-4F6B-9A21-518C24729F40Q37708588-A1ED8E00-EC97-462F-9B2C-9CB85BA39F24Q38186596-6014CA60-F2C7-4914-A9ED-413B2DE70CFBQ38478999-27E4387D-C378-4E79-ADF5-171771E1F488Q42640556-28EE5E1D-1DFD-4832-9B60-D85F8494A876Q42676936-495AEFE6-B62D-4E5A-BA10-5CCF443C4B8CQ47222156-E463CD0C-E9A1-4793-AF05-D7935B8F1CCE
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New approaches to therapy.
@en
New approaches to therapy.
@nl
type
label
New approaches to therapy.
@en
New approaches to therapy.
@nl
prefLabel
New approaches to therapy.
@en
New approaches to therapy.
@nl
P1476
New approaches to therapy.
@en
P2093
Peter Jenner
P304
P356
10.1016/B978-0-12-381328-2.00005-5
P577
2011-01-01T00:00:00Z